Plasma transfusion being administered

UK blood plasma ban lifted for life-saving treatments

The Government has lifted a ban on UK-sourced blood plasma being used in the manufacture of potentially life-saving treatments, a move which could soon benefit thousands of critically-ill patients.

It relates to a restriction introduced back in 1998 on donations of plasma in the UK being used to manufacture some medicines, known as immunoglobulins.

These medicines are manufactured from plasma donated by the public and are used to treat several serious diseases and conditions, including those with severely-reduced immune systems due to long-term cancer treatment or people with antibody deficiencies.

The recommendation to lift the ban came following a review by medicine safety experts at the independent Commission on Human Medicines (CHM) who concluded the use of UK-sourced plasma to manufacture these immunoglobulin treatments is safe and can recommence, provided it is supported by a robust set of safety measures.

In lifting the ban in England, the Government can begin to use plasma donations from UK blood donors to manufacture these potentially life-saving medicines for use with NHS patients.

The Government is also expected also introduce a new condition to ensure UK plasma is used first for UK patients and not exported to meet contracts elsewhere.

Health Minister Lord Bethell said: “Following expert advice, I am pleased we are now able to lift this ban to help thousands of NHS patients access these potentially life-saving treatments as quickly as possible.

“The move will also help England become self-sufficient and we will not have to rely only on imports from other countries, ensuring every NHS patient can always access the treatments they need.

“The safety of NHS patients remains our absolute priority and we have put in place robust precautionary measures to ensure every batch is safe.”


NHS Blood and Transplant Chief Executive Betsy Bassis added: “This is an exciting opportunity for the UK to reduce its dependence on the US for critical plasma-derived medicines on which so many patients depend.”

“We are so pleased that our donors’ gifts will now be able to save and improve even more lives in the years ahead. This is an exciting day for donors and patients alike.”

The original 1998 ban was introduced in response to concerns over the spread of a human variant of BSE, called Creutzfeldt Jakob Disease - colloquially known as ‘mad cow’s disease.

NHE May/June 22

NHE May/June 22

Developing a high-quality NHS estate

The new edition of NHE’s e-magazine highlights the latest in cyber security, pharmaceuticals, NHS workforce, NHS Estates, driving innovation in procurement and more with articles from the likes of Brendan Griffin-Ryan, Senior Category Manager, Estates & Facilities, NHS SBS (pg79), West London NHS Trust and Health Education England.


View all videos
National Health Executive Presents

National Health Executive Presents

NHE365 Virtual Events

NHE has created a full calendar of events to address the most important issues that influence the delivery of healthcare services. Over 365 days you'll have the opportunity to hear from a range of highly motivating, informative and inspirational speakers. These speakers will equip you with the knowledge and unique insight to enable you to overcome the challenges that you face.

Finger on the Pulse

Ep 14. Health messaging is a science, Professor Craig Jackson

On Episode 14 of NHE's Finger on the Pulse podcast, we're joined by Professor Craig Jackson, Professor of Occupational Health Psychology
Birmingham City University to discuss the coronavirus pandemic, the health messaging around it and how those in power have missed a trick by overlooking the key role of psychology in informing the public of restrictions, measures and the ever-changing situation

More articles...

View all